Lymphoma Research Foundation Establishes the Kanti R. Rai, MD Clinical Scholar Program for the Ongoing Study of Chronic Lymphocytic Leukemia (CLL)
Retrieved on:
Tuesday, August 23, 2022
Research, CEO, LRF, Program, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Feinstein Institute for Medical Research, SAB, Chronic lymphocytic leukemia, Kanti, Physician, Donald, Rai, Medical research, CLL, Molecular medicine, Foundation, NEW, Leadership, United States Air Force Scientific Advisory Board, Hofstra University, Cancer, Oncology, Mentorship, Patient, Pharmaceutical industry, Medicine, Lymphoma
NEW YORK, Aug. 23, 2022 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF) – the nation's largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – today announced the creation of the Kanti R. Rai, MD Clinical Scholar program to fund the ongoing study of lymphoma and chronic lymphocytic leukemia (CLL). Established in recognition of Dr. Rai's global leadership in the field of lymphoma/CLL research and his commitment to LRF's mission, the first award associated with the program will be announced in Spring 2023.
Key Points:
- Lymphoma Research Foundation Announces Creation Of The Kanti R. Rai, MD Clinical Scholar Program To Fund The Study Of Lymphoma And Chronic Lymphocytic Leukemia (CLL).
- NEW YORK, Aug. 23, 2022 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF) the nation's largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services today announced the creation of the Kanti R. Rai, MD Clinical Scholar program to fund the ongoing study of lymphoma and chronic lymphocytic leukemia (CLL).
- Each year, LRF will award one participant in its Lymphoma Scientific Research Mentoring Program (LSRMP) with the Kanti R. Rai, MD Clinical Scholar award.
- "This investment in early career scientists will strengthen the pipeline of lymphoma/ CLL research for decades to come and be instrumental in shaping the next generation of CLL experts," said Meghan Gutierrez, CEO of Lymphoma Research Foundation.